✦ LIBER ✦

Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 4 trial

✍ Scribed by Christopher P Cannon; Carolyn H McCabe; Daniel J Diver; Steve Herson; Robert M Greene; Prediman K Shah; Raphael F Sequeira; Ferdinand Leya; James M Kirshenbaum; Raymond D Magorien; Sebastian T Palmeri; Vicki Davis; C.Michael Gibson; W.Kenneth Poole; Eugene Braunwald

Book ID: 119170425
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 607 KB
Volume: 24
Category: Article
ISSN: 1558-3597
DOI: 10.1016/0735-1097(94)90163-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A pilot trial of recombinant desulfatohi

A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial

✍ Christopher P. Cannon; Carolyn H. McCabe; Timothy D. Henry; Marc J. Schweiger; R 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 607 KB

Frequency of “optimal anticoagulation” f

Frequency of “optimal anticoagulation” for acute myocardial infarction after thrombolysis with front-loaded recombinant tissue-type plasminogen activator and conjunctive therapy with recombinant hirudin (HBW O23)

✍ Uwe Zeymer; Rainer von Essen; Ulrich Tebbe; Walter Niederer; Wolfgang Mäurer; Al 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 615 KB

The use of tissue-type plasminogen activ

The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: Results from thrombolysis in myocardial infarction phase I, open label studies and the thrombolysis in myocardial infarction phase II pilot study

✍ Bernard R. Chaitman; Bruce Thompson; Mark D. Wittry; David Stump; William P. Ham 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 857 KB

A randomized placebo-controlled trial of

A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction

✍ Elizabeth G. Nabel; Eric J. Topol; Anita Galeana; Stephen G. Ellis; Eric R. Bate 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 837 KB

Sequential combination thrombolytic ther

Sequential combination thrombolytic therapy for acute myocardial infarction: results of the pro-urokinase and t-PA enhancement of thrombolysis (PATENT) trial

✍ Stuart W. Zarich; Glen J. Kowalchuk; W.Douglas Weaver; Joseph Loscalzo; Michael 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 892 KB

A difference between front-loaded strept

A difference between front-loaded streptokinase and standard-dose recombinant tissue-type plasminogen activator in preserving left ventricular function after acute myocardial infarction (the Central Illinois Thrombolytic Therapy Study)

✍ George J. Taylor; H.Weston Moses; Deborah Koester; Jerry A. Colliver; Richard E. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 726 KB